Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery

Anesthesia and Analgesia

Volumn 83, Issue 1, 1996, Pages 18-26

  Shore Lesserson, Linda ^a,c   Reich, David L ^a   Vela Cantos, Frances ^a   Ammar, Tameshwar ^a   Arisan Ergin, M ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Mt Sinai Liver Cancer Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; FRESH FROZEN PLASMA; HEPARIN; MUSCLE RELAXANT AGENT; PLACEBO; PROTAMINE; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; FEMALE; HEART SURGERY; HEART VALVE REPLACEMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REOPERATION; STROKE; SURGICAL DRAINAGE; THROMBOCYTE TRANSFUSION;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; DRAINAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; REOPERATION; TRANEXAMIC ACID;

EID: 0030004024     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199607000-00005     Document Type: Article

References (26)

1. Adelman B, Rizk A, Hanners E. Plasminogen interactions with platelets in plasma. Blood 1988;72:1530-5.
2. Horrow JC, Hlavacek J, Strong MD, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 1990;99:70-4.
3. Daily PO, Lamphere JA, Dembitsky WP, et al. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;108:99-108.
4. Gravlee GP. Autologous platelet-rich plasma in cardiac surgery: aesthetics versus virtue [editorial]. J Cardiothorac Vasc Anesth 1993;7:1-3.
5. van den Dungen AM, Karliczek GF, Brenken U, et al. Clinical study of blood trauma during perfusion with membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982;83:108-16.
6. Horrow JC, Van Riper DF, Strong MD, et al. The dose-response relationship of tranexamic acid. Anesthesiology 1995;82:383-92.
7. Speekenbrink RGH, Vonk ABA, Wildevuur CRH, Eijsman L. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. Ann Thorac Surg 1995;59:438-42.
8. Hardy JF, Perrault J, Tremblay N, et al. The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases. Can J Anaesth 1991;38:511-7.
9. Blauhut B, Harringer W, Bettelheim P, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:1083-91.
10. Gram J, Janetzko T, Despersen J, et al. Enhanced effective fibrinolysis following the neutralisation of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost 1990;63:241-5.
11. Holloway DS, Summaria L, Sandesara J, et al. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988;59:62-7.
12. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987;2:1289-91.
13. Horrow JC, Van Riper DF, Strong MD, et al. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991;84:2063-70.
14. van Oeveren W, Harder MF, Roozendaal KJ, et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
15. Soslau G, Horrow J, Brodsky I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991;38:113-9.
16. Plotz FB, Van Oeveren W, Aloe LS, et al. Prophylactic administration of tranexamic acid preserves platelet numbers during extracorporeal circulation in rabbits. ASAIO Trans 1991;37: M416-7.
17. Lytle BW, Loop FD, Cosgrove DM, et al. Fifteen hundred coronary reoperations: results and determinants of early and late survival. J Thorac Cardiovasc Surg 1987;93:847-59.
18. Whitten CW, Allison PM, Latson TW, et al. Thromboelastographic fibrinolysis does not correlate with levels of D-dimers after cardiopulmonary bypass [abstract]. Anesthesiology 1991;75:A432.
19. Karski JM, Teasdale SJ, Norman P, et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. J Thorac Cardiovasc Surg 1995;110:835-42.
20. Murkin JM, Shannon NA, Guiraudon GM, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994;107:554-61.
21. Cosgrove DM, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992;54:1031-8.
22. Brown RS, Thwaites BK, Mongan PD, Bouska GW. Aprotinin (Aprot) offers no advantage over tranexamic acid (TA) in high risk cardiac surgery [abstract]. Anesthesiology 1995;83:A97.
23. Horrow JC, Van Riper DF, Strong MD, et al. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991;84:2063-70.
24. Pugh SC, Wielogorski AK. A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1995;9:240-4.
25. Ovrum E, Holen EA, Abdelnoor M, et al. Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg 1993;105:78-83.
26. Moser KM, Cantor JP, Olman M, et al. Chronic pulmonary thromboembolism in dogs treated with tranexamic acid. Circulation 1991;83:1371-9.